Key Metrics
CiteScore 

18.8
Eigenfactor 

0.01 - 0.05
H-Index 

150
Impact Factor 

15 - 20
Scite Index 

0.89 5-Year SI

SJR 

Q1Oncology

SNIP 

3.17
Recommended pre-submission checks
Powered by 

Topics Covered on Neuro-Oncology
Neuro-Oncology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Neuro-Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Neuro-Oncology
MAPK-driven glioma progression and reprogramming of the tumor-associated immune response.
- 30 Jun 2026
- Neuro-oncology
Inferring DNA Methylation Class from Digitized Pathology Images and AI: A Worthy and Timely Application with Room for Improved Clinical Performance.
- 30 Jun 2026
- Neuro-oncology
The clinical and molecular landscape of thalamic glioma.
- 30 Jun 2026
- Neuro-oncology
Tumor-Targetedpan-RASInhibitionas a Novel Biologic Therapy forDiffuse Midline Glioma.
- 29 Jun 2026
- Neuro-oncology
A MYCN-GAL-SREBP1 Lipogenic Axis Drives Proliferation in Silent Corticotroph Adenomas.
- 23 Jun 2026
- Neuro-oncology
The critical issue of grade 2 vs grade 3 in IDH-mutant gliomas.
- 23 Jun 2026
- Neuro-oncology
MAPK-driven glioma progression and reprogramming of the tumor-associated immune response.
- 30 Jun 2026
- Neuro-oncology
Inferring DNA Methylation Class from Digitized Pathology Images and AI: A Worthy and Timely Application with Room for Improved Clinical Performance.
- 30 Jun 2026
- Neuro-oncology
The clinical and molecular landscape of thalamic glioma.
- 30 Jun 2026
- Neuro-oncology
Tumor-Targetedpan-RASInhibitionas a Novel Biologic Therapy forDiffuse Midline Glioma.
- 29 Jun 2026
- Neuro-oncology
A MYCN-GAL-SREBP1 Lipogenic Axis Drives Proliferation in Silent Corticotroph Adenomas.
- 23 Jun 2026
- Neuro-oncology
The critical issue of grade 2 vs grade 3 in IDH-mutant gliomas.
- 23 Jun 2026
- Neuro-oncology